Latest news
Non-opioid painkiller developer Latigo (LTGO.US) seeks to ride the biotech IPO boom with an offering priced at $18 per share, aiming to raise $346 millions - BitgetBitget · Fri, 07 Aug 2026 00:31:08 GMTDevelopers Riding The Surf Park Wave With Resorts, Retail And Residences - BisnowBisnow · Thu, 30 Jul 2026 23:05:00 GMT